The risk of developing myocarditis – an inflammation of the heart muscle – following a booster dose of the Pfizer COVID-19 vaccine is low, according to new research from Israel
China, the Covid nightmare is back: the industrial cities affected by the new coronavirus measures are Chengdu, Dalian, Guangzhou, Shenzhen and Shijiazhuang
The monoclonal antibody Nimotuzumab has demonstrated, during several years of clinical trials, its efficacy in the treatment of patients with cancer, and more recently in the use for the therapy of severe forms of COVID-19
The next step of the COVID-19 booster rollout will involve a “bivalent” vaccine that targets the ever-evolving Omicron variant. The vaccine isn’t here yet, but will likely be available in the fall
Bivalent vaccine against Covid: the country is the first to approve Moderna's drug which tackles both the original Wuhan strain and the first variant of Omicron and will be part of the autumn booster campaign
Laboratory medicine has historically been poorly understood, undervalued, and often overlooked. Over the past two and a half years, however, the COVID-19 pandemic has been a catalyst for a greater appreciation for laboratory medicine, and a…